Supplements on Semaglutide: Evidence-Based Nutrient Support

Last reviewed: May 21, 2026

Last updated: May 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

When taking semaglutide, reduced food intake may lower absorption of critical nutrients like B12, folate, iron, and calcium—conditions that warrant baseline lab work and ongoing monitoring. Research shows GLP-1 users report decreased nutrient intake within the first 12 weeks of therapy, making supplementation discussion with a healthcare provider essential.

Supplement strategy on semaglutide is not one-size-fits-all; it depends on individual lab values, genetic factors affecting nutrient absorption, and potential medication interactions. PlexusDx emphasizes precision-guided support: understanding your baseline micronutrient status and genetic predispositions in nutrient pathways helps providers recommend targeted interventions rather than generic multivitamins.

Why Nutrient Monitoring Matters During GLP-1 Therapy

GLP-1 receptor agonists slow gastric emptying and reduce appetite, often leading to lower overall food volume and caloric intake. This reduction can deplete stores of nutrients that depend on adequate dietary consumption, particularly those stored in limited quantities or requiring regular replenishment.

Clinical studies note that patients on semaglutide may experience deficiencies in B12, folate, iron, and vitamin D within 6–12 months of consistent use. Baseline lab testing before starting therapy establishes individual nutritional status and guides which supplements, if any, are medically appropriate for your specific situation.

Key Nutrients at Risk and Evidence-Based Considerations

The following table outlines nutrients commonly affected by reduced food intake and what clinical evidence suggests about supplementation. Individual needs vary significantly based on diet, absorption capacity, and genetic factors—your provider should interpret lab results before recommending dosages.

Nutrient	Why At Risk	Monitoring Approach	Typical Concern Level
Vitamin B12	Reduced animal product intake; intrinsic factor changes	Baseline serum B12 or methylmalonic acid; recheck at 6–12 months	Moderate to High
Folate	Lower vegetable consumption; pregnancy planning concern	Baseline folate or methylfolate; repeat annually if supplementing	Moderate
Iron	Reduced red meat/legume intake; female reproductive losses	Serum ferritin, TIBC, hemoglobin baseline and q12mo	Moderate
Vitamin D	Reduced dairy/fortified foods; malabsorption risk	25-OH vitamin D baseline; recheck at 6 months post-therapy start	Moderate to High

Genetic Factors Influencing Nutrient Absorption and Metabolism

Individual genetic variations affect how efficiently your body absorbs, processes, and stores nutrients. Variants in genes controlling folate metabolism (MTHFR), B12 transport (FI, TCBLR1), and iron regulation (HFE) can influence whether a standard supplement dose meets your needs or requires adjustment.

Some individuals carry genetic predispositions that increase their sensitivity to nutrient depletion or reduce their capacity to convert supplemental forms into active compounds. Understanding these pathways through genetic assessment may help your provider select appropriate supplement forms and dosages, rather than relying solely on population averages.

How to Work With Your Provider on Supplement Strategy

Before starting semaglutide, request comprehensive micronutrient labs: serum B12, folate, iron panel, vitamin D, and calcium if you have osteoporosis risk factors. This baseline data allows your provider to identify pre-existing deficiencies and establish a monitoring schedule aligned with your GLP-1 therapy timeline.

Discuss all supplements, medications, and herbal products with your healthcare provider to avoid interactions. Some supplements can affect GLP-1 efficacy or increase gastrointestinal side effects; timing and formulation matter significantly. Your provider may recommend specific supplement brands, dosages, or timing windows to optimize absorption and minimize additional GI upset.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context on your genetic predispositions in nutrient absorption and metabolism pathways, including genes affecting folate, B12, and iron handling. This information should be interpreted with a qualified healthcare provider to inform personalized supplement recommendations alongside clinical lab data.

The genetic test reveals predispositions in nutrient-metabolism genes—not exact supplement requirements or guaranteed deficiency outcomes. When combined with baseline micronutrient labs and clinical assessment, this genetic context can support a more informed conversation with your provider about whether standard supplement doses align with your individual biology.

Integrating genetic insights with lab work creates a precision-wellness framework: instead of guessing which supplements you need, your provider can align recommendations with both your measured nutrient status and your genetic capacity for nutrient absorption and metabolism.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.